Skip to content
  • Home
  • Book Bag: 0 items (Full)
    • English
    • 日本語
    • 中文(简体)
    • 中文(繁體)
    • اللغة العربية
  • About
Advanced
  • Editorial: Hepatocellular carc...
  • Cite this
  • Text this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Add to Book Bag Remove from Book Bag
  • Permanent link

Editorial: Hepatocellular carcinoma: novel treatment strategies, volume III

Bibliographic Details
Published in:Frontiers in Medicine
Main Authors: Fan Feng, Xiaojie Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-09-01
Subjects:
HCC
liver cancer
therapeutic strategies
TKIs
ICIs
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2025.1690673/full
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2025.1690673/full

Similar Items

  • HBV reactivation and its effect on survival in HBV-related hepatocarcinoma patients undergoing transarterial chemoembolization combined with tyrosine kinase inhibitors plus immune checkpoint inhibitors
    by: Jiaming Shen, et al.
    Published: (2023-05-01)
  • Combination immunotherapy in hepatocellular carcinoma: synergies among immune checkpoints, TKIs, and chemotherapy
    by: Suoyi Dai, et al.
    Published: (2025-09-01)
  • Animal Models of Hepatocellular Carcinoma: Current Applications in Clinical Research
    by: Fornari F, et al.
    Published: (2022-12-01)
  • Hepatocellular carcinoma: Advances in systemic therapies [version 2; peer review: 2 approved, 1 approved with reservations]
    by: Lung-Yi Mak, et al.
    Published: (2024-05-01)
  • Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Progresses and Challenges
    by: Hao-Tian Liu, et al.
    Published: (2021-10-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs